| Item Number | Description | Schedule Fee |
|---|---|---|
| 61563 | Whole body prostate-specific membrane antigen PET study performed for the initial staging of intermediate to high-risk prostate adenocarcinoma, for a previously untreated patient who is considered suitable for locoregional therapy with curative intent Applicable once per lifetime (R) |
$1,300.00 |
| Total: | $1,300.00 | |